Therefore, the findings propose a potential therapeutic role for the p53R211* mutant in RA by modulating immune and inflammatory pathways, shedding light on the intricate relationship between p53 mutations and autoimmune diseases (Figure 4) (40). The gene discussed is TP53; the disease is rheumatoid arthritis.